Lessons learned from the use of convalescent plasma for the treatment of COVID-19 and specific considerations for immunocompromised patients

Coronavirus disease 2019 (COVID-19) convalescent plasma (CovCP) infusions have been widely used for the treatment of hospitalized patients with COVID-19. The aims of this narrative review were to analyze the safety and efficacy of CovCP infusions in the overall population and in immunocompromised pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Beraud, Mickael, Goodhue Meyer, Erin, Lozano, Miquel, Bah, Aicha, Vassallo, Ralph, Brown, Bethany L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757642/
https://www.ncbi.nlm.nih.gov/pubmed/35063360
http://dx.doi.org/10.1016/j.transci.2022.103355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757642/
https://www.ncbi.nlm.nih.gov/pubmed/35063360
http://dx.doi.org/10.1016/j.transci.2022.103355

Ejemplares similares